Literature DB >> 28209582

Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with 15O-Gas PET and DSC-MRI.

S Hara1, Y Tanaka2, Y Ueda1, S Hayashi1, M Inaji1,3, K Ishiwata3, K Ishii3, T Maehara1, T Nariai1,3.   

Abstract

BACKGROUND AND
PURPOSE: Arterial spin-labeling MR imaging with multiple postlabeling delays has a potential to evaluate various hemodynamic parameters. To clarify whether arterial spin-labeling MR imaging can identify CBF and perfusion delay in patients with Moyamoya disease, we compared arterial spin-labeling, DSC, and 15O-gas PET in terms of their ability to identify these parameters.
MATERIALS AND METHODS: Eighteen patients with Moyamoya disease (5 men, 13 women; ages, 21-55 years) were retrospectively analyzed. CBF values of pulsed continuous arterial spin-labeling using 2 postlabeling delays (short arterial spin-labeling, 1525 ms; delayed arterial spin-labeling, 2525 ms) were compared with CBF values measured by 15O-gas PET. All plots were divided into 2 groups by the cutoff of time-based parameters (the time of the maximum observed concentration, TTP, MTT, delay of MTT to cerebellum, and disease severity [symptomatic or not]). The ratio of 2 arterial spin-labeling CBFs (delayed arterial spin-labeling CBF to short arterial spin-labeling CBF) was compared with time-based parameters: time of the maximum observed concentration, TTP, and MTT.
RESULTS: The short arterial spin-labeling-CBF values were significantly correlated with the PET-CBF values (r = 0.63; P = .01). However, the short arterial spin-labeling-CBF value dropped in the regions with severe perfusion delay. The delayed arterial spin-labeling CBF overestimated PET-CBF regardless of the degree of perfusion delay. Delayed arterial spin-labeling CBF/short arterial spin-labeling CBF was well correlated with the time of the maximum observed concentration, TTP, and MTT (ρ = 0.71, 0.64, and 0.47, respectively).
CONCLUSIONS: Arterial spin-labeling using 2 postlabeling delays may detect PET-measured true CBF and perfusion delay in patients with Moyamoya disease. Provided its theoretic basis and limitations are considered, noninvasive arterial spin-labeling could be a useful alternative for evaluating the hemodynamics of Moyamoya disease.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28209582      PMCID: PMC7960228          DOI: 10.3174/ajnr.A5068

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  37 in total

1.  Moyamoya disease: evaluation of postoperative revascularization using multiphase selective arterial spin labeling MRI.

Authors:  Tsukasa Saida; Tomohiko Masumoto; Yasunobu Nakai; Masanari Shiigai; Akira Matsumura; Manabu Minami
Journal:  J Comput Assist Tomogr       Date:  2012 Jan-Feb       Impact factor: 1.826

Review 2.  Arterial spin-labeled perfusion MRI in basic and clinical neuroscience.

Authors:  John A Detre; Jiongjiong Wang; Ze Wang; Hengyi Rao
Journal:  Curr Opin Neurol       Date:  2009-08       Impact factor: 5.710

3.  Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.

Authors:  Tae Jin Yun; Chul-Ho Sohn; Moon Hee Han; Hyun-Seung Kang; Jeong Eun Kim; Byung-Woo Yoon; Jin Chul Paeng; Seung Hong Choi; Ji-hoon Kim; In Chan Song; Kee-Hyun Chang
Journal:  Invest Radiol       Date:  2013-11       Impact factor: 6.016

4.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

5.  Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).

Authors: 
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

6.  Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.

Authors:  Manus J Donahue; Michael Ayad; Ryan Moore; Matthias van Osch; Robert Singer; Paul Clemmons; Megan Strother
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

7.  Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.

Authors:  Tomoyuki Noguchi; Masatou Kawashima; Masashi Nishihara; Tetsuyoshi Hirai; Toshio Matsushima; Hiroyuki Irie
Journal:  Eur J Radiol       Date:  2013-09-01       Impact factor: 3.528

8.  H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans.

Authors:  F Q Ye; K F Berman; T Ellmore; G Esposito; J D van Horn; Y Yang; J Duyn; A M Smith; J A Frank; D R Weinberger; A C McLaughlin
Journal:  Magn Reson Med       Date:  2000-09       Impact factor: 4.668

9.  Arterial Spin Labeling Magnetic Resonance Imaging Estimation of Antegrade and Collateral Flow in Unilateral Middle Cerebral Artery Stenosis.

Authors:  Jinhao Lyu; Ning Ma; David S Liebeskind; Danny J J Wang; Lin Ma; Yang Xu; Ting Wang; Zhongrong Miao; Xin Lou
Journal:  Stroke       Date:  2016-01-05       Impact factor: 7.914

Review 10.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.

Authors:  David C Alsop; John A Detre; Xavier Golay; Matthias Günther; Jeroen Hendrikse; Luis Hernandez-Garcia; Hanzhang Lu; Bradley J MacIntosh; Laura M Parkes; Marion Smits; Matthias J P van Osch; Danny J J Wang; Eric C Wong; Greg Zaharchuk
Journal:  Magn Reson Med       Date:  2014-04-08       Impact factor: 4.668

View more
  13 in total

1.  4D ASL-based MR angiography for visualization of distal arteries and leptomeningeal collateral vessels in moyamoya disease: a comparison of techniques.

Authors:  Osamu Togao; Akio Hiwatashi; Makoto Obara; Koji Yamashita; Daichi Momosaka; Ataru Nishimura; Koichi Arimura; Nobuhiro Hata; Koji Yoshimoto; Koji Iihara; Marc Van Cauteren; Hiroshi Honda
Journal:  Eur Radiol       Date:  2018-05-08       Impact factor: 5.315

2.  Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with 15O-Gas PET and Singular Value Decomposition.

Authors:  S Hara; Y Tanaka; S Hayashi; M Inaji; T Maehara; M Hori; S Aoki; K Ishii; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-10       Impact factor: 3.825

3.  Spatial coefficient of variation of arterial spin labeling MRI for detecting hemodynamic disturbances measured with 15O-gas PET in patients with moyamoya disease.

Authors:  Shoko Hara; Yoji Tanaka; Motoki Inaji; Shihori Hayashi; Kenji Ishii; Tadashi Nariai; Taketoshi Maehara
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

4.  Myelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya Disease.

Authors:  S Hara; M Hori; A Hagiwara; Y Tsurushima; Y Tanaka; T Maehara; S Aoki; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-27       Impact factor: 3.825

5.  High Intravascular Signal Arterial Transit Time Artifacts Have Negligible Effects on Cerebral Blood Flow and Cerebrovascular Reserve Capacity Measurement Using Single Postlabel Delay Arterial Spin-Labeling in Patients with Moyamoya Disease.

Authors:  M Fahlström; A Lewén; P Enblad; E-M Larsson; J Wikström
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-27       Impact factor: 3.825

6.  Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.

Authors:  Audrey P Fan; Jia Guo; Mohammad M Khalighi; Praveen K Gulaka; Bin Shen; Jun Hyung Park; Harsh Gandhi; Dawn Holley; Omar Rutledge; Prachi Singh; Tom Haywood; Gary K Steinberg; Frederick T Chin; Greg Zaharchuk
Journal:  Stroke       Date:  2017-08-01       Impact factor: 7.914

7.  The value of a shorter-delay arterial spin labeling protocol for detecting cerebrovascular impairment.

Authors:  Caiyu Zhuang; Julien Poublanc; Larissa Mcketton; Lakshmikumar Venkatraghavan; Olivia Sobczyk; James Duffin; Adrian P Crawley; Joseph A Fisher; Renhua Wu; David J Mikulis
Journal:  Quant Imaging Med Surg       Date:  2021-02

8.  Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease.

Authors:  Shihao He; Ziqi Liu; Yanchang Wei; Ran Duan; Zongsheng Xu; Cai Zhang; Li Yuan; Tian Li; Ning Ma; Xin Lou; Xiaoyuan Liu; Rong Wang
Journal:  BMC Neurosci       Date:  2021-05-12       Impact factor: 3.288

9.  Diagnostic Accuracy of Screening Arterial Spin-Labeling MRI Using Hadamard Encoding for the Detection of Reduced CBF in Adult Patients with Ischemic Moyamoya Disease.

Authors:  K Setta; T Matsuda; M Sasaki; T Chiba; S Fujiwara; M Kobayashi; K Yoshida; Y Kubo; M Suzuki; K Yoshioka; K Ogasawara
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-20       Impact factor: 4.966

10.  Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.

Authors:  Ji Young Ha; Young Hun Choi; Seunghyun Lee; Yeon Jin Cho; Jung Eun Cheon; In One Kim; Woo Sun Kim
Journal:  Korean J Radiol       Date:  2019-06       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.